- Home
- ASB vs PCVX Comparison
ASB vs PCVX Comparison
Compare ASB & PCVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASB
- PCVX
- Stock Information
- Founded
- ASB 1861
- PCVX 2013
- Country
- ASB United States
- PCVX United States
- Employees
- ASB N/A
- PCVX N/A
- Industry
- ASB Major Banks
- PCVX Biotechnology: Pharmaceutical Preparations
- Sector
- ASB Finance
- PCVX Health Care
- Exchange
- ASB Nasdaq
- PCVX Nasdaq
- Market Cap
- ASB 4.4B
- PCVX 4.0B
- IPO Year
- ASB N/A
- PCVX 2020
- Fundamental
- Price
- ASB $24.77
- PCVX $45.28
- Analyst Decision
- ASB Hold
- PCVX Strong Buy
- Analyst Count
- ASB 12
- PCVX 8
- Target Price
- ASB $28.00
- PCVX $114.17
- AVG Volume (30 Days)
- ASB 1.8M
- PCVX 1.6M
- Earning Date
- ASB 10-23-2025
- PCVX 11-05-2025
- Dividend Yield
- ASB 3.88%
- PCVX N/A
- EPS Growth
- ASB N/A
- PCVX N/A
- EPS
- ASB 0.98
- PCVX N/A
- Revenue
- ASB $1,097,713,000.00
- PCVX N/A
- Revenue This Year
- ASB $56.69
- PCVX N/A
- Revenue Next Year
- ASB $5.83
- PCVX N/A
- P/E Ratio
- ASB $25.25
- PCVX N/A
- Revenue Growth
- ASB 8.93
- PCVX N/A
- 52 Week Low
- ASB $18.32
- PCVX $27.66
- 52 Week High
- ASB $28.18
- PCVX $116.00
- Technical
- Relative Strength Index (RSI)
- ASB 43.42
- PCVX 66.85
- Support Level
- ASB $24.98
- PCVX $43.12
- Resistance Level
- ASB $25.97
- PCVX $45.69
- Average True Range (ATR)
- ASB 0.75
- PCVX 1.67
- MACD
- ASB -0.06
- PCVX -0.12
- Stochastic Oscillator
- ASB 33.89
- PCVX 90.79
About ASB Associated Banc-Corp
Associated Banc-Corp is a bank holding company. The company through its subsidiaries provides a broad array of banking and nonbanking products and services to individuals and businesses. The company operates in three reportable segments; Corporate and Commercial Specialty; Community, Consumer, and Business; and Risk Management and Shared Services. The majority of its revenue is derived from the Corporate and Commercial Specialty and Community, Consumer, and Business segments.
About PCVX Vaxcyte Inc.
Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.